These companies could innovate their way to success.

As giant companies, especially in technology, propel the S&P 500 to new heights, a select group of mid-sized companies are ...

Discover why CLLS is a top speculative Buy, with promising CAR-T therapies, strong big pharma partnerships, and attractive ...

CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

Investors are exhibiting more scrutiny around artificial-intelligence players, and that has led to some pain in the technology sector during the month of November. MarketWatch looked at the ...

To compile our list of the best short squeeze stocks, we made use of stocks screeners to note down stocks with significant ...

BENGALURU, Nov 26 (Reuters) - Most major global stock indexes should trade higher by the end of 2026 but will struggle to repeat this year's surprisingly strong performance, according to a Reuters ...